||WO||WO/2014/111949 - INTERMEDIATES AND PROCESS FOR THE PREPARATION OF HIGH PURITY FINGOLIMOD HYDROCHLORIDE||24.07.2014||
||PCT/IN2013/000044||NATCO PHARMA LIMITED||KONAKANCHI, Durga Prasad|
The present invention relates to a simple and commercially feasible preparation of Fingolimod hydrochloride with high purity of greater than 99.9%. The.present invention also provides novel intermediates for the preparation of Fingolimod Hydrochloride of Formula 1.
||WO||WO/2014/111948 - TASK ASSIGNMENT IN CROWDSOURCING||24.07.2014||
||PCT/IN2013/000036||HEWLETT-PACKARD DEVELOPMENT COMPANY, L. P||CHANDRA, Praphul|
Systems and methods for task assignment in crowdsourcing are described. In one implementation, a method comprises receiving task information from a requester, the task information comprising at least details of a task, an accuracy level for task completion, and a budget for the task. The method further comprises computing expected costs of completing the task to achieve the accuracy level within the budget based on the task information, and recommending an assignment of the task to agents based on the computation.
||WO||WO/2014/111950 - SYSTEM AND METHOD FOR CONTACT MERGE MANAGEMENT||24.07.2014||
||PCT/IN2013/000729||TURAKHIA, Bhavin||TURAKHIA, Bhavin|
In various example embodiments, a system and method for contact merge management is provided. In example embodiments, a contact management system detects that a first contact list of a first user has a first contact including a first value and a second contact including a second value. The contact management system identifies that at least one further user is associated with a further contact list that has a third contact including the first value and the second value. Based on the identifying of the third contact including the first value and the second value, the contact management system causes an automatic merge of the first contact and the second contact in the first contact list into a single contact.
||WO||WO/2014/111958 - INTERLOCKING BLOCKS||24.07.2014||
||PCT/IN2014/000038||VENKATARAMAN, Vinayak||VENKATARAMAN, Vinayak|
The present invention relates to interlocking blocks and more particularly blocks interlocking in all three dimensions without the need for binding agents or support structures. The blocks are capable of forming three dimensionally extendable structures. The blocks of the invention comprise at least one interlocking feature on a plurality of their surfaces characterized in that the block is interlockable with other similar blocks at three or more of its non-parallel surfaces.
||WO||WO/2014/111951 - A SYSTEM AND METHOD FOR SMART PUBLIC ALERTS AND NOTIFICATIONS||24.07.2014||
||PCT/IN2013/000748||TATA CONSULTANCY SERVICES LIMITED||BANERJEE, Snehasis|
Disclosed is a method and system for dynamically generating a customized, personalized and contextual alert for a user based upon personalized, contextual and background knowledge associated with the profile of the user. The system comprises a profile updater module configured to update the profile data of the user extracted either from the social web or from the user. Further, a reasoning module is configured to derive refined background knowledge in context with the updated profile data of the user. A monitoring module is configured to monitor the events sensed by a sensing module. A context extractor module is configured for extracting the context of the events and the context of the user. A knowledge converter module is configured to convert the extracted context into structured format. Finally, the refined background knowledge is steam reasoned to determine whether the events received are relevant to the user and accordingly transmitted.
||WO||WO/2014/111960 - ELASTIC MACRO POROUS SCAFFOLD AND A PROCESS FOR THE PREPARATION THEREOF||24.07.2014||
||PCT/IN2014/000040||COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH||KUMARASWAMY, Guruswamy|
The present invention discloses elastic macro porous scaffold and a process for the preparation thereof. The present invention also provides a process for the preparation of macroporous, elastic nano particulate scaffolds comprising of coated or grafted cross linkable nanoparticles, and a crosslinker prepared by crosslinking during ice templating, wherein the modulus increases linearly with temperature.
||WO||WO/2014/111954 - PROCESS FOR THE PREPARATION AND PURIFICATION OF APIXABAN||24.07.2014||
||PCT/IN2014/000029||GLENMARK PHARMACEUTICALS LIMITED; GLENMARK GENERICS LIMITED||BHIRUD, Shekhar Bhaskar|
The present invention provides a process for the preparation and purification of apixaban.
||WO||WO/2014/111952 - SYSTEM AND METHOD FOR PROVIDING SENSITIVE INFORMATION ACCESS CONTROL||24.07.2014||
||PCT/IN2013/000804||TATA CONSULTANCY SERVICES LIMITED||UKIL, Arijit|
A system and method enabling information access control of the sensitive information, based on a trust computing platform is provided. The trustworthiness of the information seekers is computed and accordingly the information owner is capacitated to decide upon sharing the information completely or sharing with some perturbation. The objective is to provide the information owner with the ability to decide on sharing its private data with respect to a parameter so that the decision is less subjective. This invention allows minimum leakage of sensitive data and makes information owner aware of the risk of privacy breach when private data is shared.
||WO||WO/2014/111957 - NITRIC OXIDE RELEASING PRODRUGS OF THERAPEUTIC AGENTS||24.07.2014||
||PCT/IN2014/000033||SATYAM, Apparao||SATYAM, Apparao|
The present invention relates to nitric oxide releasing prodrugs of known drugs or therapeutic agents wherein the drug or therapeutic agents contain at least one carboxylic acid group. The invention also relates to processes for the preparation of these nitric oxide releasing prodrugs, to pharmaceutical compositions containing them and to methods of using these prodrugs.
||WO||WO/2014/111955 - FINGOLIMOD CONTAINING STABLE COMPOSITION||24.07.2014||
||PCT/IN2014/000030||SUN PHARMACEUTICAL INDUSTRIES LTD.||JAISWAL, Sunil|
The present invention relates to a pharmaceutical composition comprising fingolimod and a weak acid cation exchange resin in the form of an ion-exchange complex and pharmaceutically acceptable excipients.